Avanos Medical AVNS Deferred Foreign Income Tax Expense Benefit
Deferred Foreign Income Tax Expense Benefit at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:DeferredForeignIncomeTaxExpenseBenefit.
The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's deferred foreign income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's deferred foreign income tax expense benefit?
- Avanos Medical (AVNS) reported deferred foreign income tax expense benefit of $50K in Q4 2025.
- How has Avanos Medical's deferred foreign income tax expense benefit changed year-over-year?
- Avanos Medical's deferred foreign income tax expense benefit increased by 122.2% year-over-year, from -$225K to $50K.
- What is the long-term trend for Avanos Medical's deferred foreign income tax expense benefit?
- Over 4 years (2021 to 2025), Avanos Medical's deferred foreign income tax expense benefit has grown at a 18.9% compound annual growth rate (CAGR), from $100K to $200K.
- What does deferred foreign income tax expense benefit mean?
- Represents the portion of deferred income tax expense or benefit attributable to foreign jurisdictions. This metric helps investors understand the impact of international tax planning and deferred tax liabilities or assets on the company's global tax position.